Lumida
/CAH
⌘K
Cardinal Health Inc

Cardinal Health Inc

CAH
$234.57USD-0.61%-1.45 today

MARKET CAP

54.6B

P/E (TTM)

35.8x

FWD P/E

DAY RANGE

$233 – $239

52W RANGE

$146
$258

AI Summary

Stalk
Sell NowMedium

CAH has decisively broken below near-term support at ~$234.25 on strong volume, activating a bearish Support Failure pattern and reflecting a Stage 3 distribution environment. This breakdown signals failure of buyer absorption and opens the path toward $230 and the 200-day SMA near $216. Short-term conditions are unfavorable for bulls, with price tracking below the 9/20 EMAs and rising selling pressure. The preferred approach is to sell into any rallies toward the $235–$238 zone or on continued downside, with invalidation only on a sustained recovery above the broken support.

  • Q4 revenue reached $63.7B (+6% YoY) with GAAP EPS $1.70 (+70%).
  • Adjusted free cash flow of $5.0B supports $0.5158/share dividend and buybacks.
  • Negative earnings yield and low book-to-price suggest potential overvaluation.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$162.5B$181.3B$205.0B$226.8B$222.6B
YoY %+6.2%+11.6%+13.0%+10.7%-1.9%
P / Sales0.1x0.1x0.1x0.1x0.2x
EV / Sales0.3x0.3x0.3x0.3x0.4x
Gross Profit, Adj.$6.8B$6.5B$6.9B$7.4B$8.2B
YoY %-1.3%-4.3%+6.0%+7.9%+10.2%
Margin %4.2%3.6%3.4%3.3%3.7%
EV / Gross Profit8.3x8.4x9.7x9.1x11.3x
EBITDA, Adj.$2.6B$2.3B$2.8B$3.1B$3.5B
YoY %-4.0%-9.2%+18.2%+12.9%+10.4%
Margin %1.6%1.3%1.3%1.4%1.6%
EV / EBITDA21.7x23.3x24.2x21.6x26.8x
EBIT$551.0M$1.5B$752.0M$1.2B$2.3B
YoY %+113.5%+163.7%-48.2%+65.3%+83.0%
Margin %0.3%0.8%0.4%0.5%1.0%
EV / EBIT101.7x37.5x89.1x54.2x40.7x
Net Income$611.0M$-938.0M$330.0M$852.0M$1.6B
YoY %+116.5%-253.5%+135.2%+158.2%+83.2%
Net Margin0.4%-0.5%0.2%0.4%0.7%
EPS (GAAP)$2.08-$3.37$1.26$3.45$6.45
YoY %+116.5%-262.0%+137.4%+173.8%+87.0%